" Our new strategy is built on four key pillars to deliver short- and long-term growth from our commercial portfolio and biosimilars, innovative pipeline, generics powerhouse and focused capital allocation ," said Richard Francis, President and CEO, Teva. "With our Pivot to Growth strategy, I am confident we will gain momentum as a stronger, bolder and simpler organization. "